Wildcard: BICO, Bioprinting, and Bioconvergence
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Wildcard: BICO, Bioprinting, and Bioconvergence
-
Narrated by:
-
By:
About this listen
We get back to Wednesday's healthcare roots with a rundown on BICO Group, a Sweden-based business that enables researchers and scientists to model, build, test, analyze and observe 3-D printed cells, tissues and organs.
This company helps researchers reduce the time and cost of identifying potentially efficacious drugs and can help provide initial results on whether drug compounds are safe and effective before having to test them on animals or humans.
We talk through the huge implications it could have for research in life sciences and personalized medicine and try to clear up some of the jargon around the company.
Stocks: (OM:BICO)
Check out more of our content here:
Podcasts
Youtube
Reach us by Email @ IndustryFocus@fool.com
No reviews yet